See ColonCancerCheck at

Slides:



Advertisements
Similar presentations
Fighting back against cancers that affect men:
Advertisements

Fight Back Against Cancer: Screening and Early Detection
This grey area will not appear in your presentation. Fighting back Against Colon Cancer Presentations prepared by: Canadian Cancer Society, Ontario Division,
1 An Update on Evolving Colorectal Screening Issues May 19, 2011 This first part today will be presented by: Stanley H. Weiss, MD, FACP, FACE  Professor,
1 Colorectal Cancer and Screening Cancer Screening Programs September 2013.
Spotlight on Colorectal Cancer Screening 1 1. Home Screening for Colon Cancer
Cancer in the Northwest Territories ( ) Highlights from the Northwest Territories Cancer Report March 2014.
Screening for Colorectal Cancer Cancer Symposium: Measuring the Benefits of Screening and Treatment October 2007.
Colorectal Cancer & Screening Sept Sometimes there are things that may be hard to talk about… But not talking about them is even harder.
Colorectal cancer: How do we approach health disparities? Marta L. Davila, MD, FASGE University of Texas MD Anderson Cancer Center.
Mobilizing Newcomers and Immigrants to Cancer Screening Programs Funded by Public Health Agency of Canada (PHAC) The views expressed herein do not necessarily.
Cancer Statistics 2013 A Presentation from the American Cancer Society
 2 nd overall leading cause of cancer death in the United States › 3 rd in each sex  Approximately 6% of individuals in the US will develop a cancer.
Colorectal Cancer Screening John Pelzel MD Sleepy Eye Medical Center.
Integrated Cancer Screening Colorectal Cancer Screening.
By Rachel, Xiao Xia, Helen. Introduction Definition Symptoms Causes Prevention Treatment Prognosis Statistics Conclusion.
World Burden of Cancer Epi 242 Cancer Epidemiology Binh Goldstein, Ph.D. October 7, 2009.
This grey area will not appear in your presentation. Cancer prevention and screening Fighting back against cancers that affect women: Presentations prepared.
Recent advances in the management of colorectal cancer Vilnius, May 6-7 Epidemiology of colorectal cancer: what we can learn from Lithuania Juozas Kurtinaitis.
Cancer Statistics 2013 A Presentation from the American Cancer Society
Our Vision – Healthy Kansans Living in Safe and Sustainable Environments.
Cancer Screening and Prevention Edition $200 $400 $600 $800 $1000 $200 $400 $600 $800 $1000 $200 $600 $800 $1000 $200 $400 $600 $800 $1000 Breast Screening.
INCIDENCE AND SURVIVAL TRENDS OF COLORECTAL CANCER FROM 2002 TO 2011 BE Ansa; E Alema-Mensah; MD Claridy; JQ Sheats; B Fontenot, and SA Smith Georgia Regents.
Unit 3 Discussion Question: Group B Could Mr. C have avoided getting colorectal cancer?
Better Health. No Hassles. Colorectal Cancer Facts – The 2 nd leading cause cancer-related deaths in the Nation – Highly preventable – Caused 49,920 deaths.
 Subhendu De, Wonsuk Yoo Institute of Public and Preventative Health (IPPH), Georgia Regents University On Summer Public Health Scholars Program (SPHSP)
CANCER CONTROL NHPA’s. What is it? Cancer is a term to describe a diverse group of diseases in which some of the cells in body become defective. The following.
Brian Cox Research Associate Professor: Cancer epidemiology and screening University of Otago Hugh Adam Cancer Epidemiology Unit Department of Preventive.
Colorectal Cancer Screening Colorectal Cancer Screening VT SGNA Conference VT SGNA Conference October 24, 2015 October 24, 2015 Lynn Butterly, MD Lynn.
Colorectal Cancer Preventa ble Beata ble Treata ble.
Definition Signs & symptoms Treatment Root of the disease.
Interventions for Clients with Colorectal Cancer.
Cancer Risk Factors in Ontario Alcohol. Proportion of cancer cases attributable to alcohol consumption, by sex and cancer type, Ontario, Cancer.
D. M. Kruss MD Colon Cancer How to nip it in the bud! Daniel M. Kruss, M.D. Colon Cancer How to nip it in the bud! Daniel M. Kruss, M.D.
Colon Cancer The Bottom Line
What you need to know about the Fecal Occult Blood Test
2 Incidence SABER This module presents statistics from Chapter 2: Incidence Ontario Cancer Statistics 2016 Chapter 2: Incidence.
Colorectal Cancer: Risk Prevention and Diagnosis
Cancer in Ontario 1 An Overview
NHS CANCER SCREENING PROGRAMMES
Lung cancer is the leading cause of cancer deaths among Ontario women
My CancerIQ™ -- cancer prevention goes digital in Ontario (Feb. 2015)
More Ontarians need to be screened for colorectal cancer (Sept. 2012)
Endometrial cancer on the rise in older women (August 2014)
Lung cancer prevalence on the rise (Nov. 2014)
In Focus 6 Spotlight on Specific Cancers TANYA
Colorectal Cancer Screening
Cancer Prevention Screening and Early Detection PROF.MAZIN AL-HAWAZ.
Cancer screening PROF .MAZIN AL-HAWAZ.
Module 4: Colorectal Cancer
It is estimated that almost 1
Colorectal Cancer.
Prepared by staff in Prevention and Cancer Control.
Prepared by staff in Prevention and Cancer Control.
Colorectal Natural History Model
Estimated current cancer incidence
Figure 1 Differences in bladder cancer between genders
Prepared by staff in Prevention and Cancer Control.
Prepared by staff in Prevention and Cancer Control.
Lung cancer mortality differences between men and women influenced by smoking trends (Apr. 2015) Trends in lung cancer mortality rates reflect past trends.
Citation: Cancer Care Ontario
Prepared by staff in Prevention and Cancer Control.
For more information, see:
Inflammatory Bowel Disease (IBD)
Seniors have highest increases in malignant melanoma (May 2013)
Supporting Patients With Colorectal Cancer
Citation: Cancer Care Ontario
Antoni Castells, Sergi Castellví–Bel, Francesc Balaguer 
Available at High smoking and obesity rates causing increased cancer risk in Ontario Métis (July 2012) Métis.
Prepared by staff in Prevention and Cancer Control.
Presentation transcript:

See ColonCancerCheck at http://health.gov.on.ca/en/ms/coloncancercheck Colorectal cancer subsite distribution differs by sex (Apr. 2010) Proximal colon cancers are most common in females, while rectal cancers are most common among males. Differences in risk factors may explain the variation in subsite proportions between sexes. The distribution of cancers occurring along subsites of the colon and rectum differs between sexes. Among females, proximal colon cancers are most common, accounting for approximately 42% of all colorectal cancers. Rectal cancers and distal colon cancers account for the second (28%) and third (22%) largest proportion of female cases, respectively. In contrast, rectal cancers are most common among males (38% of all cases), followed by cancers of the proximal (31%) and distal (25%) colon. The predominance of proximal colon cancers among females and rectal cancers among males in Ontario is consistent with patterns in other developed countries (1,2). The reasons for this sex difference, however, remain unclear. Risk factors for colorectal cancer include genetic and environmental factors such as obesity, insufficient physical activity, alcohol consumption, and red meat consumption. Hormone replacement therapy and non-steroidal anti-inflammatory drug use have a protective effect (3). Increasingly, it is being recognized that colorectal cancer risk factors, tumour characteristics, and response to treatment may vary across anatomic subsites (3,4). Differences in exposure and response to risk factors between males and females may therefore explain the varying subsite distribution of colorectal cancers observed between sexes.   Ontario’s colorectal cancer screening program, ColonCancerCheck, recommends screening Ontarians at average risk of colorectal cancer with the fecal occult blood test (FOBT) beginning at age 50. For those at increased risk (defined as a family history of one or more first degree relatives with colorectal cancer), it recommends colonoscopy for screening beginning at age 50 or 10 years younger than the age at which the relative was diagnosed, whichever occurs earlier. Screening for colorectal cancer can reduce the number of deaths from colorectal cancer by facilitating early detection of cancerous tumours and detecting and removing precancerous polyps. For more information: See ColonCancerCheck at http://health.gov.on.ca/en/ms/coloncancercheck See Insight on Colorectal Cancer: News and information on colorectal cancer and screening in Ontario at http://www.cancercare.on.ca/common/pages/UserFile.aspx?fieldID=13734 Talk to your health care provider or call Cancer Information Service (1 888 939-3333) References 1. Bray F and Larsen IK. Trends in colorectal cancer incidence in Norway 1962–2006: an interpretation of the temporal patterns by anatomic subsite. Int J Cancer 2010;126:721–732. 2. Wu XC, Chen VW, Steele B, Ruiz B, Fulton J, Liu L, et al. Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992–1997. Cancer 2001;92(10):2547–2554. 3. Giovannucci E and Wu K. Cancers of the colon and rectum. In: Schottenfeld D, Fraumeni JF, Jr., editors. Cancer epidemiology and prevention. 3rd ed. New York: Oxford University Press; 2006. p. 809–829. 4. Iacopetta B. Are there two sides to colorectal cancer? Int J Cancer 2002;101:403–408. This Ontario Cancer Fact was prepared by the Colorectal Cancer Network (CRCNet). Production of this Cancer Fact has been made possible through a financial contribution from Health Canada, through the Canadian Partnership Against Cancer. The views expressed herein do not necessarily represent the views of The Canadian Partnership Against Cancer. Citation: Cancer Care Ontario. Colorectal cancer subsite distribution differs by sex. April 2010. Available at http://www.cancercare.on.ca/english/ocs/snapshot/ont-cancer-facts/. Prepared by: The Colorectal Cancer Network (CRCNet).

See ColonCancerCheck at http://health.gov.on.ca/en/ms/coloncancercheck Colorectal cancer subsite distribution differs by sex (Apr. 2010) Proximal colon cancers are most common in females, while rectal cancers are most common among males. Differences in risk factors may explain the variation in subsite proportions between sexes. The distribution of cancers occurring along subsites of the colon and rectum differs between sexes. Among females, proximal colon cancers are most common, accounting for approximately 42% of all colorectal cancers. Rectal cancers and distal colon cancers account for the second (28%) and third (22%) largest proportion of female cases, respectively. In contrast, rectal cancers are most common among males (38% of all cases), followed by cancers of the proximal (31%) and distal (25%) colon. The predominance of proximal colon cancers among females and rectal cancers among males in Ontario is consistent with patterns in other developed countries (1,2). The reasons for this sex difference, however, remain unclear. Risk factors for colorectal cancer include genetic and environmental factors such as obesity, insufficient physical activity, alcohol consumption, and red meat consumption. Hormone replacement therapy and non-steroidal anti-inflammatory drug use have a protective effect (3). Increasingly, it is being recognized that colorectal cancer risk factors, tumour characteristics, and response to treatment may vary across anatomic subsites (3,4). Differences in exposure and response to risk factors between males and females may therefore explain the varying subsite distribution of colorectal cancers observed between sexes.   Ontario’s colorectal cancer screening program, ColonCancerCheck, recommends screening Ontarians at average risk of colorectal cancer with the fecal occult blood test (FOBT) beginning at age 50. For those at increased risk (defined as a family history of one or more first degree relatives with colorectal cancer), it recommends colonoscopy for screening beginning at age 50 or 10 years younger than the age at which the relative was diagnosed, whichever occurs earlier. Screening for colorectal cancer can reduce the number of deaths from colorectal cancer by facilitating early detection of cancerous tumours and detecting and removing precancerous polyps. For more information: See ColonCancerCheck at http://health.gov.on.ca/en/ms/coloncancercheck See Insight on Colorectal Cancer: News and information on colorectal cancer and screening in Ontario at http://www.cancercare.on.ca/common/pages/UserFile.aspx?fieldID=13734 Talk to your health care provider or call Cancer Information Service (1 888 939-3333) References 1. Bray F and Larsen IK. Trends in colorectal cancer incidence in Norway 1962–2006: an interpretation of the temporal patterns by anatomic subsite. Int J Cancer 2010;126:721–732. 2. Wu XC, Chen VW, Steele B, Ruiz B, Fulton J, Liu L, et al. Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992–1997. Cancer 2001;92(10):2547–2554. 3. Giovannucci E and Wu K. Cancers of the colon and rectum. In: Schottenfeld D, Fraumeni JF, Jr., editors. Cancer epidemiology and prevention. 3rd ed. New York: Oxford University Press; 2006. p. 809–829. 4. Iacopetta B. Are there two sides to colorectal cancer? Int J Cancer 2002;101:403–408. This Ontario Cancer Fact was prepared by the Colorectal Cancer Network (CRCNet). Production of this Cancer Fact has been made possible through a financial contribution from Health Canada, through the Canadian Partnership Against Cancer. The views expressed herein do not necessarily represent the views of The Canadian Partnership Against Cancer. Citation: Cancer Care Ontario. Colorectal cancer subsite distribution differs by sex. April 2010. Available at http://www.cancercare.on.ca/english/ocs/snapshot/ont-cancer-facts/. Prepared by: The Colorectal Cancer Network (CRCNet).